Emmanuel Houdart
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Emmanuel Houdart has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Michael Eliezer
Department of Radiology Hôpital Des 15‐20 Paris France
8 shared publications - Alexis Guédon
Department of Neuroradiology, AP-HP Nord, Hôpital Lariboisière, Paris, France
6 shared publications - Marc-Antoine Labeyrie
Interventional Neuroradiology, Lariboisière Hospital, APHP, Université Paris Cité, Paris, France
6 shared publications - Jean-Pierre Saint-Maurice
Department of Neuroradiology, AP-HP, Lariboisière Hospital, 2, rue Ambroise Paré, 75010, Paris, France
4 shared publications Jean-Pierre Saint-Maurice
service de neuroradiologie, hôpital Lariboisière, 2, rue Ambroise Paré, 75010 Paris, France
3 shared publications- Matteo Fantoni
Department of Neuroradiology, AP-HP, Lariboisière Hospital, 2, rue Ambroise Paré, 75010, Paris, France
3 shared publications
Latest Publications
- 24 August 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (9) , 2697-2706
MRI follow-up of embolized intracranial dural arteriovenous fistulas using 3D time-of-flight and contrast-enhanced 3D T1-weighted GRE imaging
Background Although digital subtraction angiography (DSA) remains the reference standard for post-treatment follow-up of intracranial dural arteriovenous fistulas (DAVFs), it is an invasive procedure associated with procedural risks and may not be justified for the follow-up of all DAVFs. Purpose This study aimed to evaluate the diagnostic performance of 3D time-of-flight (3D TOF) and contrast-enhanced 3D T1-weighted gradient-echo (3D T1 Gd) magnetic resonance imaging (MRI) sequences for monitoring embolized intracranial DAVFs. Materials and methods In this retrospective single-center study, consecutive patients with embolized DAVFs between 2004 and 2023, who underwent MRI and arteriography during follow-up, were evaluated. 3D TOF sequence images were independently reviewed by two readers to assess treatment completeness. In cases of residual fistula, cortical venous drainage (CVD) was evaluated. Patency of the fistulous or proximal venous sinus was assessed on contrast-enhanced 3D T1-weighted GRE imaging. The median follow-up duration was 3.6 months (interquartile range [IQR], 3.0–8.4 months). Imaging findings were systematically compared with DSA as the reference standard. Results Seventy-six patients (mean age, 56 ± 12,8 years; 46 men) with 78 embolized DAVFs were included. The positive predictive value, negative predictive value, and diagnostic accuracy of 3D TOF sequence for the detection of residual fistulas were 79% [54% − 94%], 93% [84% − 98%], 90% [81% − 95%], respectively. Inter-rater agreement was good (κ = 0.71; [0.52–0.90]). Intermodality agreement was good for the detection of residual fistulas (κ = 0.72; [0.54–0.90]) and moderate for the detection of cortical venous drainage (κ = 0.54; [0.22–0.85]). Additionally, agreement between 3D T1 Gd and DSA for assessing venous sinus patency was good (κ = 0.80; [0.58–1.00]). Conclusion 3D TOF and contrast-enhanced 3D T1-weighted GRE imaging are effective non-invasive tools for the follow-up of embolized DAVFs. 3D TOF provides high diagnostic performance for excluding clinically significant residual fistulas, whereas small residual microshunts or low-flow fistulas may remain occult and still require DSA confirmation in selected cases.
- 24 August 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (9) , 2697-2706
MRI follow-up of embolized intracranial dural arteriovenous fistulas using 3D time-of-flight and contrast-enhanced 3D T1-weighted GRE imaging
Background Although digital subtraction angiography (DSA) remains the reference standard for post-treatment follow-up of intracranial dural arteriovenous fistulas (DAVFs), it is an invasive procedure associated with procedural risks and may not be justified for the follow-up of all DAVFs. Purpose This study aimed to evaluate the diagnostic performance of 3D time-of-flight (3D TOF) and contrast-enhanced 3D T1-weighted gradient-echo (3D T1 Gd) magnetic resonance imaging (MRI) sequences for monitoring embolized intracranial DAVFs. Materials and methods In this retrospective single-center study, consecutive patients with embolized DAVFs between 2004 and 2023, who underwent MRI and arteriography during follow-up, were evaluated. 3D TOF sequence images were independently reviewed by two readers to assess treatment completeness. In cases of residual fistula, cortical venous drainage (CVD) was evaluated. Patency of the fistulous or proximal venous sinus was assessed on contrast-enhanced 3D T1-weighted GRE imaging. The median follow-up duration was 3.6 months (interquartile range [IQR], 3.0–8.4 months). Imaging findings were systematically compared with DSA as the reference standard. Results Seventy-six patients (mean age, 56 ± 12,8 years; 46 men) with 78 embolized DAVFs were included. The positive predictive value, negative predictive value, and diagnostic accuracy of 3D TOF sequence for the detection of residual fistulas were 79% [54% − 94%], 93% [84% − 98%], 90% [81% − 95%], respectively. Inter-rater agreement was good (κ = 0.71; [0.52–0.90]). Intermodality agreement was good for the detection of residual fistulas (κ = 0.72; [0.54–0.90]) and moderate for the detection of cortical venous drainage (κ = 0.54; [0.22–0.85]). Additionally, agreement between 3D T1 Gd and DSA for assessing venous sinus patency was good (κ = 0.80; [0.58–1.00]). Conclusion 3D TOF and contrast-enhanced 3D T1-weighted GRE imaging are effective non-invasive tools for the follow-up of embolized DAVFs. 3D TOF provides high diagnostic performance for excluding clinically significant residual fistulas, whereas small residual microshunts or low-flow fistulas may remain occult and still require DSA confirmation in selected cases.
- 1 February 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (2) , 376-384
Combined Technique for Internal Carotid Artery Terminus or Middle Cerebral Artery Occlusions in the ASTER2 Trial
BACKGROUND: The aim of this study was to report the results of a subgroup analysis of the ASTER2 trial (Effect of Thrombectomy With Combined Contact Aspiration and Stent Retriever vs Stent Retriever Alone on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion) comparing the safety and efficacy of the combined technique (CoT) and stent retriever as a first-line approach in internal carotid artery (ICA) terminus±M1-middle cerebral artery (M1-MCA) and isolated M1-MCA occlusions. METHODS: Patients enrolled in the ASTER2 trial with ICA terminus±M1-MCA and isolated M1-MCA occlusions were included in this subgroup analysis. The effect of first-line CoT versus stent retriever according to the occlusion site was assessed on angiographic (first-pass effect, expanded Treatment in Cerebral Infarction score ≥2b50, and expanded Treatment in Cerebral Infarction score ≥2c grades at the end of the first-line strategy and at the end of the procedure) and clinicoradiological outcomes (24-hour National Institutes of Health Stroke Scale, ECASS-III [European Cooperative Acute Stroke Study] grades, and 3-month modified Rankin Scale). RESULTS: Three hundred sixty-two patients were included in the postsubgroup analysis according to the occlusion site: 299 were treated for isolated M1-MCA occlusion (150 with first-line CoT) and 63 were treated for ICA terminus±M1-MCA occlusion (30 with first-line CoT). Expanded Treatment in Cerebral Infarction score ≥2b50 (odds ratio, 11.83 [95% CI, 2.32–60.12]) and expanded Treatment in Cerebral Infarction score ≥2c (odds ratio, 4.09 [95% CI, 1.39–11.94]) were significantly higher in first-line CoT compared with first-line stent retriever in patients with ICA terminus±M1-MCA occlusion but not in patients with isolated M1-MCA. CONCLUSIONS: First-line CoT was associated with higher reperfusion grades in patients with ICA terminus±M1-MCA at the end of the procedure. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03290885.
- 1 February 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (2) , 376-384
Combined Technique for Internal Carotid Artery Terminus or Middle Cerebral Artery Occlusions in the ASTER2 Trial
BACKGROUND: The aim of this study was to report the results of a subgroup analysis of the ASTER2 trial (Effect of Thrombectomy With Combined Contact Aspiration and Stent Retriever vs Stent Retriever Alone on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion) comparing the safety and efficacy of the combined technique (CoT) and stent retriever as a first-line approach in internal carotid artery (ICA) terminus±M1-middle cerebral artery (M1-MCA) and isolated M1-MCA occlusions. METHODS: Patients enrolled in the ASTER2 trial with ICA terminus±M1-MCA and isolated M1-MCA occlusions were included in this subgroup analysis. The effect of first-line CoT versus stent retriever according to the occlusion site was assessed on angiographic (first-pass effect, expanded Treatment in Cerebral Infarction score ≥2b50, and expanded Treatment in Cerebral Infarction score ≥2c grades at the end of the first-line strategy and at the end of the procedure) and clinicoradiological outcomes (24-hour National Institutes of Health Stroke Scale, ECASS-III [European Cooperative Acute Stroke Study] grades, and 3-month modified Rankin Scale). RESULTS: Three hundred sixty-two patients were included in the postsubgroup analysis according to the occlusion site: 299 were treated for isolated M1-MCA occlusion (150 with first-line CoT) and 63 were treated for ICA terminus±M1-MCA occlusion (30 with first-line CoT). Expanded Treatment in Cerebral Infarction score ≥2b50 (odds ratio, 11.83 [95% CI, 2.32–60.12]) and expanded Treatment in Cerebral Infarction score ≥2c (odds ratio, 4.09 [95% CI, 1.39–11.94]) were significantly higher in first-line CoT compared with first-line stent retriever in patients with ICA terminus±M1-MCA occlusion but not in patients with isolated M1-MCA. CONCLUSIONS: First-line CoT was associated with higher reperfusion grades in patients with ICA terminus±M1-MCA at the end of the procedure. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03290885.
- 3 August 2023
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 44 (9) , 1064-1069
Iterative Denoising Accelerated 3D FLAIR Sequence for Hydrops MR Imaging at 3T
BACKGROUND AND PURPOSE: 3D FLAIR sequences have become the criterion standard for identifying endolymphatic hydrops, but scan time remains an important limitation to their widespread use. Our purpose was to evaluate the diagnostic performance and image quality of an accelerated 3D FLAIR sequence combined with an iterative denoising algorithm. MATERIALS AND METHODS: This was a retrospective study performed on 30 patients with clinical suspicion of endolymphatic hydrops who underwent 3T MR imaging 4 hours after gadolinium injection using two 3D FLAIR sequences. The first (conventional FLAIR) was accelerated with a conventional turbo factor of 187. The second was accelerated with an increased turbo factor of 263, resulting in a 33% scan time reduction (5 minutes 36 seconds versus 8 minutes 15 seconds, respectively). A sequence was reconstructed in-line immediately after the accelerated 3D FLAIR acquisition from the same raw data with iterative denoising (accelerated-FLAIR iterative denoising). The signal intensity ratio image quality score and endolymphatic hydrops diagnosis were evaluated. RESULTS: The mean signal intensity ratio for symptomatic and asymptomatic ears of accelerated-FLAIR iterative denoising was significantly higher than the mean SNR of conventional FLAIR (29.5 versus 19 and 25.9 versus 16.3, P < .001). Compared with the conventional FLAIR sequence, the image-quality score was higher with accelerated-FLAIR iterative denoising (mean image-quality score, 3.8 [SD, 0.4] versus 3.3 [SD, 0.6] for accelerated-FLAIR iterative denoising and conventional FLAIR, respectively, P = .003). There was no significant difference in the diagnosis of endolymphatic hydrops between the 2 sequences. Interreader agreement was good-to-excellent. CONCLUSIONS: The iterative denoising algorithm applied to an accelerated 3D FLAIR sequence for exploration of endolymphatic hydrops enabled significantly reducing the scan time without compromising image quality and diagnostic performance.
- 3 August 2023
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 44 (9) , 1064-1069
Iterative Denoising Accelerated 3D FLAIR Sequence for Hydrops MR Imaging at 3T
BACKGROUND AND PURPOSE: 3D FLAIR sequences have become the criterion standard for identifying endolymphatic hydrops, but scan time remains an important limitation to their widespread use. Our purpose was to evaluate the diagnostic performance and image quality of an accelerated 3D FLAIR sequence combined with an iterative denoising algorithm. MATERIALS AND METHODS: This was a retrospective study performed on 30 patients with clinical suspicion of endolymphatic hydrops who underwent 3T MR imaging 4 hours after gadolinium injection using two 3D FLAIR sequences. The first (conventional FLAIR) was accelerated with a conventional turbo factor of 187. The second was accelerated with an increased turbo factor of 263, resulting in a 33% scan time reduction (5 minutes 36 seconds versus 8 minutes 15 seconds, respectively). A sequence was reconstructed in-line immediately after the accelerated 3D FLAIR acquisition from the same raw data with iterative denoising (accelerated-FLAIR iterative denoising). The signal intensity ratio image quality score and endolymphatic hydrops diagnosis were evaluated. RESULTS: The mean signal intensity ratio for symptomatic and asymptomatic ears of accelerated-FLAIR iterative denoising was significantly higher than the mean SNR of conventional FLAIR (29.5 versus 19 and 25.9 versus 16.3, P < .001). Compared with the conventional FLAIR sequence, the image-quality score was higher with accelerated-FLAIR iterative denoising (mean image-quality score, 3.8 [SD, 0.4] versus 3.3 [SD, 0.6] for accelerated-FLAIR iterative denoising and conventional FLAIR, respectively, P = .003). There was no significant difference in the diagnosis of endolymphatic hydrops between the 2 sequences. Interreader agreement was good-to-excellent. CONCLUSIONS: The iterative denoising algorithm applied to an accelerated 3D FLAIR sequence for exploration of endolymphatic hydrops enabled significantly reducing the scan time without compromising image quality and diagnostic performance.
- 19 May 2023
- Published by Elsevier in EMC - Otorinolaringoiatria
- Vol. 22 (2) , 1-7
Acufeni oggettivi
- 1 March 2023
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 33 (3) , 729-737
Blood Flow Velocity: a Decision Tool for Stenting Indication in Venous Pulsatile Tinnitus
Background and Purpose Lateral sinus stenosis is the most common cause of venous pulsatile tinnitus (VPT). Stenting is an effective treatment after demonstration of a trans-stenotic pressure gradient; however, pressure measurement has many technical limitations. In 2018, a study showed that a combined approach with intravascular velocity measurement could be effective in identifying most appropriate candidates for stenting. The aim of the present study was to evaluate a new strategy using this biomarker for the indication of stenting even without a significant pressure gradient. Material and Methods Consecutive patients with disabling VPT were included from 2016 to 2019 and analyzed retrospectively. Intrasinusal pressures were measured and blood flow velocities (with a dual-sensor guidewire) were used for the indication of stenting independent of the pressure gradient. We evaluated the clinical outcome after stenting based on this new biomarker. Results A total of 41 patients were treated according to this strategy. At last follow-up (mean = 30.2 months), 32/33 patients (97%) treated by stenting showed complete resolution or a significant decrease in VPT intensity. The use of velocity as the threshold for indicating stenting identified 8 patients (24%) missed by the pressure gradient. Their clinical outcome after stenting was excellent and no complications occurred. Conclusion Measurement of sinus blood flow velocity provides a hemodynamic explanation of disease and may be a better tool than pressure gradient for the indication of stenting in VPT.
- 1 March 2023
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 33 (3) , 729-737
Blood Flow Velocity: a Decision Tool for Stenting Indication in Venous Pulsatile Tinnitus
Background and Purpose Lateral sinus stenosis is the most common cause of venous pulsatile tinnitus (VPT). Stenting is an effective treatment after demonstration of a trans-stenotic pressure gradient; however, pressure measurement has many technical limitations. In 2018, a study showed that a combined approach with intravascular velocity measurement could be effective in identifying most appropriate candidates for stenting. The aim of the present study was to evaluate a new strategy using this biomarker for the indication of stenting even without a significant pressure gradient. Material and Methods Consecutive patients with disabling VPT were included from 2016 to 2019 and analyzed retrospectively. Intrasinusal pressures were measured and blood flow velocities (with a dual-sensor guidewire) were used for the indication of stenting independent of the pressure gradient. We evaluated the clinical outcome after stenting based on this new biomarker. Results A total of 41 patients were treated according to this strategy. At last follow-up (mean = 30.2 months), 32/33 patients (97%) treated by stenting showed complete resolution or a significant decrease in VPT intensity. The use of velocity as the threshold for indicating stenting identified 8 patients (24%) missed by the pressure gradient. Their clinical outcome after stenting was excellent and no complications occurred. Conclusion Measurement of sinus blood flow velocity provides a hemodynamic explanation of disease and may be a better tool than pressure gradient for the indication of stenting in VPT.
- 31 August 2022
- Published by Elsevier in Pratique Neurologique - FMC
- Vol. 13 (3) , 198-200
Embolie gazeuse cérébrale induite par un cathéter veineux périphérique
- 31 August 2022
- Published by Elsevier in Pratique Neurologique - FMC
- Vol. 13 (3) , 198-200
Embolie gazeuse cérébrale induite par un cathéter veineux périphérique
- 7 April 2022
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 32 (4) , 1131-1134
Venous Pulsatile Tinnitus: Turbulence or Dehiscence?
- 7 April 2022
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 32 (4) , 1131-1134
Venous Pulsatile Tinnitus: Turbulence or Dehiscence?
- 1 March 2022
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 103 (3) , 161-169
Computed tomography angiography for quantification of cerebral vasospasm following aneurysmal subarachnoid hemorrhage
- 1 March 2022
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 103 (3) , 161-169
Computed tomography angiography for quantification of cerebral vasospasm following aneurysmal subarachnoid hemorrhage
- 1 January 2022
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 103 (1) , 13-20
Iterative denoising accelerated 3D SPACE FLAIR sequence for brain MR imaging at 3T
- 1 January 2022
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 103 (1) , 13-20
Iterative denoising accelerated 3D SPACE FLAIR sequence for brain MR imaging at 3T
- 28 October 2021
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 42 (12) , 2194-2198
Pulsatile Tinnitus Due to Stenosis of the Marginal Sinus: Diagnosis and Endovascular Treatment
BACKGROUND AND PURPOSE: Venous pulsatile tinnitus is a disabling condition mainly caused by a stenosis of the lateral sinus. Here, we aimed to report a novel cause of venous pulsatile tinnitus, stenosis of the marginal sinus. MATERIALS AND METHODS: We retrospectively analyzed patients with isolated venous pulsatile tinnitus for which the suspected cause was a stenosis of the marginal sinus, treated or not, between January 2017 and December 2020. Patient charts and imaging were systematically reviewed. All patients underwent noncontrast temporal bone CT and MR imaging. RESULTS: Eight patients (7 women; median age, 36 years) were included. Six patients (75%) were overweight, and 1 patient had idiopathic intracranial hypertension. All patients presented with a typical venous pulsatile tinnitus. The stenosis of the marginal sinus was detected using oblique reconstructions on postcontrast 3D MR imaging. There was no other pathologic finding except ipsilateral stenosis of the lateral sinus in 3 patients. Four patients underwent endovascular therapy with placement of a stent in the marginal sinus, leading to complete resolution of the pulsatile tinnitus for all of them. No complication occurred. Of note, the symptoms of intracranial hypertension also regressed after stent placement in that patient. CONCLUSIONS: Marginal sinus stenosis is a novel cause of venous pulsatile tinnitus, which can be easily detected on MR imaging. Marginal sinus stent placement is safe and efficient. We hypothesized that the marginal sinus stenosis pathophysiology is similar to that of lateral sinus stenosis, which is a common and well-known cause of venous pulsatile tinnitus, explaining the similar clinical presentation and endovascular management.
- 28 October 2021
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 42 (12) , 2194-2198
Pulsatile Tinnitus Due to Stenosis of the Marginal Sinus: Diagnosis and Endovascular Treatment
BACKGROUND AND PURPOSE: Venous pulsatile tinnitus is a disabling condition mainly caused by a stenosis of the lateral sinus. Here, we aimed to report a novel cause of venous pulsatile tinnitus, stenosis of the marginal sinus. MATERIALS AND METHODS: We retrospectively analyzed patients with isolated venous pulsatile tinnitus for which the suspected cause was a stenosis of the marginal sinus, treated or not, between January 2017 and December 2020. Patient charts and imaging were systematically reviewed. All patients underwent noncontrast temporal bone CT and MR imaging. RESULTS: Eight patients (7 women; median age, 36 years) were included. Six patients (75%) were overweight, and 1 patient had idiopathic intracranial hypertension. All patients presented with a typical venous pulsatile tinnitus. The stenosis of the marginal sinus was detected using oblique reconstructions on postcontrast 3D MR imaging. There was no other pathologic finding except ipsilateral stenosis of the lateral sinus in 3 patients. Four patients underwent endovascular therapy with placement of a stent in the marginal sinus, leading to complete resolution of the pulsatile tinnitus for all of them. No complication occurred. Of note, the symptoms of intracranial hypertension also regressed after stent placement in that patient. CONCLUSIONS: Marginal sinus stenosis is a novel cause of venous pulsatile tinnitus, which can be easily detected on MR imaging. Marginal sinus stent placement is safe and efficient. We hypothesized that the marginal sinus stenosis pathophysiology is similar to that of lateral sinus stenosis, which is a common and well-known cause of venous pulsatile tinnitus, explaining the similar clinical presentation and endovascular management.